The Effects of Peroneal Nerve Functional Electrical Stimulation Versus Ankle-Foot Orthosis in Patients With Chronic Stroke
| Autor: | Carolyn Geis, Subramani Seetharama, Karen J. Nolan, Pramod Sethi, Arun Jayaraman, Jason Greenberg, Judith M. Burnfield, Conrad Kufta, Sangeetha Madhavan, Barbara Browne, Farha S Ikramuddin, Wuwei Feng, Thiru M. Annaswamy, Roi Ann Wallis, Noel Rao, Gary W. Abrams, Mark Gudesblatt, William S. Pease, Murray E. Brandstater, Steven A. Kautz, Mitchell J. Freed, Helmi L. Lutsep, Helen L. Rogers, Margaret A. Turk, Francois Bethoux, Jill Meilahn |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Foot drop Foot Orthoses Electric Stimulation Therapy law.invention Physical medicine and rehabilitation Randomized controlled trial Quality of life law Ankle/foot orthosis medicine Humans Functional electrical stimulation In patient Chronic stroke Gait Disorders Neurologic Aged Foot business.industry Stroke Rehabilitation Peroneal Nerve Recovery of Function General Medicine Middle Aged Gait speed Stroke Chronic Disease Quality of Life Physical therapy Female Ankle medicine.symptom business |
| Zdroj: | Neurorehabilitation and Neural Repair. 28:688-697 |
| ISSN: | 1552-6844 1545-9683 |
| Popis: | Background. Evidence supports peroneal nerve functional electrical stimulation (FES) as an effective alternative to ankle-foot orthoses (AFO) for treatment of foot drop poststroke, but few randomized controlled comparisons exist. Objective. To compare changes in gait and quality of life (QoL) between FES and an AFO in individuals with foot drop poststroke. Methods. In a multicenter randomized controlled trial (ClinicalTrials.gov #NCT01087957) with unblinded outcome assessments, 495 Medicare-eligible individuals at least 6 months poststroke wore FES or an AFO for 6 months. Primary endpoints: 10-Meter Walk Test (10MWT), a composite of the Mobility, Activities of Daily Living/Instrumental Activities of Daily Living, and Social Participation subscores on the Stroke Impact Scale (SIS), and device-related serious adverse event rate. Secondary endpoints: 6-Minute Walk Test, GaitRite Functional Ambulation Profile (FAP), Modified Emory Functional Ambulation Profile (mEFAP), Berg Balance Scale (BBS), Timed Up and Go, individual SIS domains, and Stroke-Specific Quality of Life measures. Multiply imputed intention-to-treat analyses were used with primary endpoints tested for noninferiority and secondary endpoints tested for superiority. Results. A total of 399 subjects completed the study. FES proved noninferior to the AFO for all primary endpoints. Both the FES and AFO groups improved significantly on the 10MWT. Within the FES group, significant improvements were found for SIS composite score, total mFEAP score, individual Floor and Obstacle course time scores of the mEFAP, FAP, and BBS, but again, no between-group differences were found. Conclusions. Use of FES is equivalent to the AFO. Further studies should examine whether FES enables better performance in tasks involving functional mobility, activities of daily living, and balance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|